Recombinant CD38 (Isatuximab Biosimilar) antibody
The Human Chimeric anti-CD38 (Isatuximab Biosimilar) antibody is suitable to detect CD38 (Isatuximab Biosimilar) in samples from Human. It has been validated for ELISA and WB.
Catalog No. ABIN7538067
$213.13
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant CD38 (Isatuximab Biosimilar) antibody (ABIN7538067)
Target
CD38 (Isatuximab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human, Mouse
Clonality
Chimeric
Conjugate
This CD38 (Isatuximab Biosimilar) antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Isatuximab Biosimilar - Anti-CD38 mAb - Research Grade
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- CD38 (Isatuximab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Isatuximab is a humanized monoclonal antibody derived from IgG1 that targets CD38, a glycoprotein found on the surface of some immune cells. CD38 is highly expressed by malignant plasma cells in multiple myeloma. Isatuximab is used to treat multiple myeloma.
-
CAS-No
- 1461640-62-9
Target
-
You are here:
